Market Research Logo

Gastrointestinal Market Research Reports & Industry Analysis

Gastrointestinal (GI) or gastroenterology is the branch of medicine related to the GI tract (stomach and intestines) and the accessory organs of digestion (from the mouth to the anus). Some of the conditions treated under this specialty include but are not limited to: Crohn’s disease, gastroesophageal reflux disease (GERD), inflammatory bowel disease, irritable bowel syndrome, peptic ulcer disease, celiac disease, colon cancer, heartburn, gastric cancer, diverticulitis, and ulcerative colitis.

While many of these illnesses are chronic and can only be treated medically, more holistic and natural approaches are being used more frequently to prevent and manage gastrointestinal disorders. Many healthcare providers are recommending stress management, a healthy diet, and exercise to prevent and manage symptoms.

Exercise has shown to decrease the risk of colon cancer, minimize constipation and improve overall GI health. Even minimal exercise paired with a healthy diet of fruits, vegetables, low fat protein and avoidance of red meat, animal fat, and processed meats, can go a long way in preventing colon cancer and other GI diseases.

It is known that psychological stress can aggravate symptoms of Crohn’s disease, irritable bowel syndrome, and ulcerative colitis. Taking a mind-body approach to health can help these patients manage their illnesses. Techniques such as yoga, meditation, massage, and acupuncture can lower stress and in turn reduce bowel symptoms. Doctors also recommend an anti-inflammatory diet (omega-3 fatty acids, fruits & vegetables, and protein rich food like fish, chicken and soy) for people suffering from Crohn’s disease.

...Show More ...Show Less


Filter your search

Research Assistance

Join Alert Me Now!

Sign Up

Find out more on our blog

Gastrointestinal Industry Research & Market Reports

  • OpportunityAnalyzer: Opioid-Induced Constipation - Opportunity Analysis and Forecasts to 2019

    ...and 2019. The main drivers of growth will be an increase in the diagnosed OIC population. This is fuelled by a relaxation of regulations regarding opioid treatment, particularly in the chronic non-cancer pain population. As ... Read More

  • Gastrointestinal Stromal Tumor (GIST) - Pipeline Review, H2 2015

    ...report provides comprehensive information on the therapeutic development for Gastrointestinal Stromal Tumor (GIST), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule ... Read More

  • Gastroenteritis - Pipeline Review, H2 2015

    ...Gastroenteritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ... Read More

  • Digestive Remedies in South Africa

    ...South Africans continue to educate themselves on healthcare, many chose to self-medicate and focus on preventive health and wellness issues as opposed to reactively treating ailments with medicines Euromonitor International's Digestive Remedies in South Africa ... Read More

  • Digestive Remedies in Ireland

    ...from more recent product launches that were focused on PPI’s and H2 blockers, Rapidol Express contains 250mg of Phycodol. This is a proprietary high-quality alginate extract derived from the Laminaria sp, which is a type ... Read More

  • Traveler's Diarrhea - Pipeline Review, H2 2015

    ...therapeutic development for Traveler's Diarrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ... Read More

  • Diarrhea - Pipeline Review, H2 2015

    ...Diarrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ... Read More

  • OpportunityAnalyzer: Clostridium difficile Infections (CDI) - Opportunity Analysis and Forecasts to 2024

    ...associated with colitis, as well as C. difficile-associated diarrhea (CDAD). CDI onset begins with colonization of the intestinal tract with C. difficile through community-acquired or healthcare-associated means. C. difficile has been identified as a major ... Read More

  • Colitis - Pipeline Review, H2 2015

    ...Colitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ... Read More

  • Trends to Watch in Digestive Health

    ...products and their purchasing habits within the OTC category. Synopsis Identify five emerging trends influencing innovation in the OTC digestive health space, including the latest on-trend innovation examples. Understand how consumer trends such as Fresh ... Read More

  • Nausea - Pipeline Review, H2 2015

    ...Nausea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ... Read More

  • Gastric Ulcers - Pipeline Review, H2 2015

    ...therapeutic development for Gastric Ulcers, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ... Read More

  • Germany Gastro-Esophageal Reflux Disease Market Highlights – 2015

    ...forecast in Germany. The research includes Germany gastro-esophageal reflux disease market size estimates for 2014, market share forecast for six years to 2020, gastro-esophageal reflux disease drugs market share, gastro-esophageal reflux disease drugs sales estimates, ... Read More

  • UK Gastro-Esophageal Reflux Disease Market Highlights – 2015

    ...forecast in UK. The research includes UK gastro-esophageal reflux disease market size estimates for 2014, market share forecast for six years to 2020, gastro-esophageal reflux disease drugs market share, gastro-esophageal reflux disease drugs sales estimates, ... Read More

  • France Gastro-Esophageal Reflux Disease Market Highlights – 2015

    ...forecast in France. The research includes France gastro-esophageal reflux disease market size estimates for 2014, market share forecast for six years to 2020, gastro-esophageal reflux disease drugs market share, gastro-esophageal reflux disease drugs sales estimates, ... Read More

  • Italy Irritable Bowel Syndrome Market Highlights – 2015

    ...forecast in Italy. The research includes Italy irritable bowel syndrome market size estimates for 2014, market share forecast for six years to 2020, irritable bowel syndrome drugs market share, irritable bowel syndrome drugs sales estimates, ... Read More

  • US Irritable Bowel Syndrome Market Highlights – 2015

    ...sales forecast in the US. The research includes the US irritable bowel syndrome market size estimates for 2014, market share forecast for six years to 2020, irritable bowel syndrome drugs market share, irritable bowel syndrome ... Read More

  • Europe Irritable Bowel Syndrome Market Highlights – 2015

    ...for Germany, France, Italy, Spain, and UK. The research includes Europe (Germany, France, Italy, Spain, and UK) irritable bowel syndrome market size estimates for 2014, market share forecast for six years to 2020, irritable bowel ... Read More

  • Japan Gastro-Esophageal Reflux Disease Market Highlights – 2015

    ...forecast in Japan. The research includes Japan gastro-esophageal reflux disease market size estimates for 2014, market share forecast for six years to 2020, gastro-esophageal reflux disease drugs market share, gastro-esophageal reflux disease drugs sales estimates, ... Read More

  • Germany Irritable Bowel Syndrome Market Highlights – 2015

    ...forecast in Germany. The research includes Germany irritable bowel syndrome market size estimates for 2014, market share forecast for six years to 2020, irritable bowel syndrome drugs market share, irritable bowel syndrome drugs sales estimates, ... Read More

  • Spain Irritable Bowel Syndrome Market Highlights – 2015

    ...forecast in Spain. The research includes Spain irritable bowel syndrome market size estimates for 2014, market share forecast for six years to 2020, irritable bowel syndrome drugs market share, irritable bowel syndrome drugs sales estimates, ... Read More

  • Japan Irritable Bowel Syndrome Market Highlights – 2015

    ...forecast in Japan. The research includes Japan irritable bowel syndrome market size estimates for 2014, market share forecast for six years to 2020, irritable bowel syndrome drugs market share, irritable bowel syndrome drugs sales estimates, ... Read More

  • France Irritable Bowel Syndrome Market Highlights – 2015

    ...forecast in France. The research includes France irritable bowel syndrome market size estimates for 2014, market share forecast for six years to 2020, irritable bowel syndrome drugs market share, irritable bowel syndrome drugs sales estimates, ... Read More

  • UK Ulcerative Colitis Market Highlights – 2015

    ...research includes UK ulcerative colitis market size estimates for 2014, market share forecast for six years to 2020, ulcerative colitis drugs market share, ulcerative colitis drugs sales estimates, ulcerative colitis drugs sales forecast, and ulcerative ... Read More

  • France Ulcerative Colitis Market Highlights – 2015

    ...research includes France ulcerative colitis market size estimates for 2014, market share forecast for six years to 2020, ulcerative colitis drugs market share, ulcerative colitis drugs sales estimates, ulcerative colitis drugs sales forecast, and ulcerative ... Read More

6 7 8 9 11 13 14 15